
About Nanogap
Nanogap is a Technology company based in Santiago De Compostela (Spain) founded in 2006. It operates as a silver-based nanomaterials are manufactured using controlled wet chemistry. It operates in the Technology and Chemicals & Materials sectors. Nanogap has raised $2.78 million across 7 funding rounds from investors including European Union, EIC Fund and Caixa Capital Risc. Nanogap offers products and services including Metal Molecules, Nanofibers, and Nanoparticles. Its focus areas include High Tech, Advanced Materials, Nanostructures and Metal and Metalloid. Its competitors include Noble Biomaterials, Cambrios, Innova Dynamics, Crayonano and Shenzhen Huake Chuangzhi Technology and 4 more; 8 of its 9 listed competitors have raised funding.
Company details
Nanogap was established in 2006 as a spinout from the University of Santiago de Compostela in Spain. Operations focus on the production of silver-based nanomaterials through a controlled wet chemistry platform. Atomic quantum clusters, nanoparticles, and nanofibers are generated for applications in conductive inks, luminescent materials, antimicrobial coatings, and therapeutic uses within the nanotechnology sector.
- Headquarters Santiago De Compostela, Spain
- SectorsTechnologyChemicals & Materials
- Emailβ’β’β’β’β’β’β’β’
- Website nanogap.es
- Social LinkedIn X YouTube
- Total Equity Funding$2.78M (USD)
in 7 rounds
- Latest Funding Round$438.12K (USD), Grant
Jan 2019
- InvestorsEuropean Union
& 2 more
Products & Services of Nanogap
Nanogap offers a comprehensive portfolio of products and services, including Metal Molecules, Nanofibers, and Nanoparticles.
Sub-nanometer materials for catalysis in energy and health applications.
Fibers used in nanotechnology for various industrial applications.
Particles for catalysis and remediation in environmental sectors.
Apps and channels of Nanogap
its YouTube channel Nanogap has 2 subscribers and 1 videos.
Videos from Nanogap
The most watched videos on Nanogap's YouTube channel, Nanogap (2 subscribers). Click a video to play it here.
More on Nanogap.
Funding Insights of Nanogap
Nanogap has successfully raised a total of $2.78M across 7 strategic funding rounds. The most recent funding activity was a Grant round of $438.12 thousand completed in January 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $2.78M
- Total Rounds 7
- Last Round Grant β $438,120
- First Round $2.78M
(Oct 2014)
- Investors Count 3
All 7 funding rounds of Nanogap with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2019 | $438,120 | Grant | β | β | |
| Jan 2017 | $236,517 | Grant | β | β | |
| Aug 2016 | $55,822 | Grant | β | β | |
| Mar 2016 | $54,360 | Grant | β | β | |
| Sep 2015 | $136,908 | Grant | β | β | |
| Jan 2015 | $297,863 | Grant | β | β | |
| Oct 2014 | $2.78M | Series A | β | β |
3 investors in total: 3 institutional.
Investors in Nanogap
Nanogap has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union, EIC Fund and Caixa Capital Risc.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government agency and accelerator focusing on innovative startups and SMEs | – | eicfund.eu | Brussels, Belgium | |
Venture capital investments are focused on healthcare and multiple sectors. | – | caixacapitalrisc.es | Barcelona, Spain | |
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for Nanogap
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Nanogap
11 people are tracked at Nanogap (3 in leadership, 4 in board & advisors, 4 in team).
| Name | Role | Group |
|---|---|---|
Allen Reid | Commercial Director | Leadership |
Darren Bianchi | President, U.S. | Leadership |
David Buceta | Technical Director | Leadership |
Fernando Dominguez | Advisor | Board & advisors |
Carlos Vázquez | Advisor | Board & advisors |
M. Arturo Lopez Quintela | Advisor | Board & advisors |
José Rivas | Advisor | Board & advisors |
Vanessa Piñeiro García | Departamento De Administración Y Finanzas | Team |
Eldara Rodríguez Cobo | Responsable Innovacion | Team |
Javier Rivela | General Member Board | Team |
Noelia Maria Canedo Rodriguez | Directora Financiera | Team |
Complete people profiles for Nanogap
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Nanogap
3 dated milestones of Nanogap across 13 years, from founding to its latest funding, stage changes and deals.
- Founded Nanogap is founded.
- Funding First funding round of $2.8M.
- Funding Latest funding round, Grant, of $438K.
Competitors of Nanogap
Nanogap has 9 listed competitors in our database, 8 of them funded. They include Noble Biomaterials, Cambrios, Innova Dynamics, Crayonano and Shenzhen Huake Chuangzhi Technology, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| noblebiomaterials.com | 2005 | United States | $8.01M | 100 | Silver-based antimicrobial technologies are developed for diverse markets. | |
| cambrios.com | 2004 | Sunnyvale, United States | $63.41M | – | Silver nanowire solutions are developed for transparent conductors in electronics. | |
| innovadynamics.com | 2008 | San Francisco, United States | $5.5M | – | Transparent conductive electrodes are formed via surface embedding technology. | |
| crayonano.com | 2012 | Trondheim, Norway | – | 24 | Graphene-based nanowires are provided for UV LED applications. | |
| huake-tek.com | 2014 | Shenzhen, China | $14.4M | – | Silver nanowire technology and products are developed for industrial applications. | |
| plextronics.com | 2002 | Pittsburgh, United States | $57.05M | 31 | Conductive polymers and inks are developed for electronic printing applications. | |
| advancedsilicongroup.com | 2015 | Boston, United States | $1.03M | – | Silicon nanowire IP is licensed and consulting services are offered. | |
| cimananotech.com | 2003 | Oakdale, United States | $21.47M | – | Silver nanoparticle-based conductive films are developed for touch screens. | |
| enwires.com | 2015 | Grenoble, France | $6.22M | – | Tech-based solutions for silicon nanowires are provided. |
Detailed competitors of Nanogap
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Nanogap
The website of Nanogap (nanogap.es) receives about 1.9K visits a month.
- Monthly visits1.9K
▲ 59.2% vs previous month
Websites whose visitors overlap most with Nanogap. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
capsulution.com | capsulution.com | 100% | – | #3,311,802 | β |
| hybridplastics.com | 100% | 1.8K | #6,871,765 | View details | |
bionanomatrix.com | bionanomatrix.com | 100% | – | – | β |
| firstnano.com | 100% | – | – | View details | |
nanopchem.com | nanopchem.com | 100% | – | – | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 15 similar websites and full traffic analytics for Nanogap
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 15 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Nanotechnology
10 companies that operate in the same segment as Nanogap (Nanotechnology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Developer of technologies for analysis of genetic variation and function | 1993 | San Diego, California, United States | USD 28 M | USD 1.44 M | 29 | |
RNA interference-based therapeutics are developed for multiple disorders. | 2002 | Cambridge, Massachusetts, United States | USD 17 M | USD 3.71 B | 2,230 | |
Technology tools and systems for molecular scale are developed. | 1959 | Abingdon, Oxfordshire, United Kingdom | – | USD 648.1 M | – | |
Aerogel-based thermal insulation solutions are provided for energy conservation. | 2001 | United States | USD 198.35 M | USD 271.1 M | 554 | |
Nanotech-based electrode materials for supercapacitors are provided. | 2009 | Boston, Massachusetts, United States | USD 163.32 M | – | 66 | |
Instrument systems and software for single-molecule real-time sequencing are developed. | 2004 | Menlo Park, California, United States | USD 395 M | USD 160 M | 575 | |
Nanotech-based wound care products are developed and provided. | 2010 | Madison, Wisconsin, United States | USD 22.7 M | – | 35 | |
Conductive nanocoatings are delivered via atomic layer deposition technology. | 2013 | Boulder, Colorado, United States | USD 202.75 M | – | – | |
RNA therapeutics for hematology and cardiovascular diseases are developed. | 1999 | London, England, United Kingdom | – | USD 559 K | 116 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Nanogap
Complete news archive for Nanogap
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nanogap
Nanogap was founded in 2006 and raised its 1st funding round 8 years after it was founded.
Nanogap is headquartered in Santiago De Compostela, Spain. It is registered at Santiago De Compostela, Galicia, Spain.
Nanogap is a funded company, having raised a total of $2.78M across 7 funding rounds to date. The company's 1st funding round was a Series A of $2.78M, raised on Oct 2014.
Nanogap was established in 2006 as a spinout from the University of Santiago de Compostela in Spain. Operations focus on the production of silver-based nanomaterials through a controlled wet chemistry platform. Atomic quantum clusters, nanoparticles, and nanofibers are generated for applications in conductive inks, luminescent materials, antimicrobial coatings, and therapeutic uses within the nanotechnology sector.
Nanogap's top competitors include Innova Dynamics, Crayonano and Cambrios.
Nanogap offers Metal Molecules, Nanofibers, and Nanoparticles.
Nanogap has 3 investors. Key investors include European Union, EIC Fund, and Caixa Capital Risc.
